Market open
Senseonics/SENS
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Senseonics
Senseonics Holdings Inc is a medical technology company. It is focused on the design, development, and commercialization of glucose monitoring system, which helps people to manage their diabetes community with differentiated, long-term implantable glucose management technology. Its products and services include a Continuous glucose monitoring system, Sensor, Smart transmitter, and Mobile app. The firm has a Glucose monitoring product segment. The majority of the revenue is generated outside of the United States.
Ticker
SENS
Sector
Trading on
AMEX
Industry
Health Care Equipment & Supplies
Headquarters
Employees
132
Website
Senseonics Metrics
BasicAdvanced
$177M
Market cap
-
P/E ratio
-$0.13
EPS
0.80
Beta
-
Dividend rate
Price and volume
Market cap
$177M
Beta
0.8
52-week high
$0.75
52-week low
$0.32
Average daily volume
5.8M
Financial strength
Current ratio
3.111
Quick ratio
2.741
Long term debt to equity
105.173
Total debt to equity
154.972
Interest coverage (TTM)
-8.91%
Management effectiveness
Return on assets (TTM)
-34.80%
Return on equity (TTM)
-125.30%
Valuation
Price to revenue (TTM)
8.365
Price to book
305.75
Price to tangible book (TTM)
305.75
Price to free cash flow (TTM)
-3.027
Growth
Revenue change (TTM)
30.25%
Earnings per share change (TTM)
-2.03%
3-year revenue growth (CAGR)
30.62%
3-year earnings per share growth (CAGR)
-57.59%
What the Analysts think about Senseonics
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Senseonics stock.
Senseonics Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Senseonics Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Senseonics News
AllArticlesVideos
Mercy Places First Commercial Eversense 365: The World's First and Only 365-Day Continuous Glucose Monitor
GlobeNewsWire·23 hours ago
Eversense 365 Receives FDA Clearance: The World's First One Year CGM
GlobeNewsWire·3 weeks ago
Senseonics Holdings, Inc. to Participate in the Upcoming H.C. Wainwright 26th Annual Global Investment Conference
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Senseonics stock?
Senseonics (SENS) has a market cap of $177M as of October 11, 2024.
What is the P/E ratio for Senseonics stock?
The price to earnings (P/E) ratio for Senseonics (SENS) stock is 0 as of October 11, 2024.
Does Senseonics stock pay dividends?
No, Senseonics (SENS) stock does not pay dividends to its shareholders as of October 11, 2024.
When is the next Senseonics dividend payment date?
Senseonics (SENS) stock does not pay dividends to its shareholders.
What is the beta indicator for Senseonics?
Senseonics (SENS) has a beta rating of 0.8. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.